M E 33 (Erlotinib Hydrochloride 150 mg)
Pill with imprint M E 33 is White, Round and has been identified as Erlotinib Hydrochloride 150 mg. It is supplied by Mylan Pharmaceuticals Inc.
Erlotinib is used in the treatment of non-small cell lung cancer; pancreatic cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Erlotinib 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M E 33
Erlotinib Hydrochloride
- Imprint
- M E 33
- Strength
- 150 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- EGFR inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-7133
Related images for "M E 33"
More about erlotinib
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (42)
- Drug images
- Pricing & coupons
- En español
- Drug class: EGFR inhibitors
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.